Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeuroVice
AddedFeb 19, 2024
UpdatedJun 18, 2026
NeuroVice

NeuroVice

Angel

NeuroVice, LLC: Innovating disruptive medical device technology for enhanced patient self-care.

HQ
Cary, NC, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

NeuroVice, LLC, founded with a mission to revolutionize patient self-care through innovative medical device technology, focuses on enhancing the patient experience, particularly for those with neurological disorders. Their flagship product, PATI, is an FDA-cleared device designed to improve oral health during seizures, offering a safer and more effective alternative to traditional methods. NeuroVice aims to empower patients by providing tools that enable them to manage their health more independently.

The company has garnered attention for its groundbreaking approach and has attracted notable investors and advisors from the medical and tech industries. Key achievements include the FDA clearance of PATI, which marks a significant milestone in their mission to improve seizure management. NeuroVice's impact is evident in its commitment to addressing a critical need in the epilepsy community, ultimately enhancing the quality of life for patients worldwide.

NeuroVice - Similar Companies

Epic Neuro logo

Epic Neuro

Neurodyne logo

Neurodyne

Neuroview Technology logo

Neuroview Technology

neuroviewtech.com

Neurvana Medical logo

Neurvana Medical

Neurava logo

Neurava

NeuroPace logo

NeuroPace

neuropace.com

NeuroBionics logo

NeuroBionics

NeuRx Medical logo

NeuRx Medical

neurxmed.com

Progressive Nuero logo

Progressive Nuero

NeuraLace Medical logo

NeuraLace Medical

Neuright logo

Neuright

neurightlabs.com

Neurolutions logo

Neurolutions

neurolutions.com

Cadence Neuroscience logo

Cadence Neuroscience

NeuroX Innovations logo

NeuroX Innovations

Mivi Neuroscience logo

Mivi Neuroscience

mivineuro.com

NeuroVice - Quick Facts

Who are NeuroVice's competitors?

Companies similar to NeuroVice include Epic Neuro, Neurodyne, Neuroview Technology and Neurvana Medical.

When was NeuroVice founded?

NeuroVice was founded in 2016.

Where is NeuroVice's headquarters located?

NeuroVice's headquarters is located in Cary, NC, US.

When was NeuroVice's last funding round?

NeuroVice's most recent funding round was for $300k (USD) in February 2021.

How much has NeuroVice raised to-date?

As of Feb 3, 2021, NeuroVice has raised a total of $300k (USD).

How many employees does NeuroVice have?

NeuroVice has 5 employees as of Feb 4, 2024.

NeuroVice - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthtech
  • Medical Devices
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified